Evidence map›Paper›PMID 34383269›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2021

Revisiting the Innovation Strategy performance measurement process: insights from practice.

Michèle Boileau-Falardeau, Shermeen Farooqi, Christine O'Rourke, Leslie Payne

Abstract read
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Readiness for scale-up: lessons learned from the Public Health Agency of Canada's Innovation Strategy.Canadian journal of public health = Revue canadienne de sante publique · 2021
    Article
  2. Article
  3. Linking to and addressing the determinants of health: a review of the Innovation Strategy experience.Canadian journal of public health = Revue canadienne de sante publique · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michèle Boileau-FalardeauHealth Promotion and Chronic Disease Prevention Branch/Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Public Health Agency of Canada/Agence de la santé publique du Canada, Ottawa, ON, Canada.
Shermeen FarooqiHealth Promotion and Chronic Disease Prevention Branch/Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Public Health Agency of Canada/Agence de la santé publique du Canada, Ottawa, ON, Canada.
Christine O'RourkeHealth Promotion and Chronic Disease Prevention Branch/Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Public Health Agency of Canada/Agence de la santé publique du Canada, Ottawa, ON, Canada.
Leslie PayneHealth Promotion and Chronic Disease Prevention Branch/Direction générale de la promotion de la santé et de la prévention des maladies chroniques, Public Health Agency of Canada/Agence de la santé publique du Canada, Ottawa, ON, Canada. leslie.payne@canada.ca.ORCID 0000-0002-1462-4063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Performance measurement (PM) aims to ensure transparency and effectiveness in public spending. More specifically, it provides a foundation that allows funders to determine whether an intervention has achieved its stated objective, thus improving understanding of what interventions should be funded in the future. Ideally, performance measurement should help us understand "what works, for whom, and in what context." Unfortunately, more often than not, performance reports are limited to a collection of indicators that make it difficult to answer this question. Based on our work with the Public Health Agency of Canada Innovation Strategy (PHAC-IS), we offer several recommendations to address this issue and support the performance measurement process, especially for complex interventions. We discuss the importance of contextualizing results to better understand impact and associating these results to a well-defined intervention. We also suggest using a validated tool to improve data collection and analysis and critically appraise the methods used to collect impact information. The integration of these key considerations will save time in data analysis and ensure funded recipients are not overburdened by the data collection process. Although this commentary is presented within the context of a complex multi-year population health funding program, we believe our approach can be applied to any performance management process and ultimately improve decisions such as whether an intervention should be continued, scaled up, or adapted to different contexts.

Indexed as

Diffusion of InnovationProgram EvaluationPublic Health AdministrationCanadaHumansPerformance measurementStrategic grantmaking

Identifiers

PMID34383269
PMCPMC8360244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.